A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11562625.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study was conducted to investigate whether a single dose of nebulized budesonide effectively decreased airway inflammation as demonstrated by exhaled nitric oxide (eNO) levels. A single dose of nebulized budesonide, but not nebulized terbutaline, rapidly decreased eNO levels in 6 hours. The decrease in eNO levels induced by nebulized budesonide was correlated to an increase in peak expiratory flow rate.
Medical subject headings
- Asthma
- Bronchodilator Agents
- Budesonide
- Nitric Oxide
- Terbutaline